Randomised clinical trial, parallel, double blind, to evaluate the influence of the ASA-SR ([aspirin] slow release) in the platelet parameters and the oxidative status, in patients with coronary disease of chronic evolution during 12 months
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Aspirin (Primary)
- Indications Coronary artery disease; Embolism and thrombosis; Myocardial ischaemia
- Focus Pharmacodynamics
- 13 Aug 2007 New trial record.
- 18 Jul 2007 Biomarkers information updated